NCT00364247View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.

PHASE3CompletedINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

Not specified

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
ArthralgiaBunionHallux ValgusPain AssessmentTapentadol
Interventions
DRUG

CG5503 IR;tapentadol

Sponsors

Collaborators (1)

Grünenthal GmbH
All Listed Sponsors
collaborator

Grünenthal GmbH

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00364247 - A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety. | Biotech Hunter | Biotech Hunter